Koya Taro, Otsuka Naoto, Tri Jason A, Sauer William H, Asirvatham Samuel J, Nguyen Duy T
Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Cardiac Arrhythmia Service, Brigham and Woman's Hospital, Boston, Minnesota, USA.
J Cardiovasc Electrophysiol. 2024 Dec;35(12):2354-2360. doi: 10.1111/jce.16439. Epub 2024 Oct 3.
Pulsed field ablation (PFA) has emerged as an innovative therapy for cardiac arrhythmias. Drawing parallels with PFA's application in solid tumors, calcium chloride (CaCl) as an adjuvant therapy, known as calcium electroporation, may amplify PFA's apoptotic effects. We propose that PFA in the atrium could enhance calcium uptake through PFA-created pores, thereby increasing ablation efficacy even at reduced power levels by exploiting PFA's permeabilization effects.
We conducted in vivo ablations on the atria of seven pigs using low PFA power (250 V, 20 μs for 50 pulses at 200 ms intervals). Post-PFA, we randomly administered an infusion of either 200 mg/2 ml CaCl (calcium group) or saline (control) directly to the ablation site via the catheter tip. We evaluated reduction in electrogram voltage amplitude, electrocardiography (ECG) parameters, ablation lesion parameters, and histology after PFA.
Nineteen lesions from control and calcium groups were examined. Control lesions showed no voltage decrease post-PFA, whereas calcium-treated lesions exhibited a significant voltage reduction. Gross pathology indicated marked differences in maximum lesion surface diameter, depth, and volume between the lesion groups. Histologically, calcium group lesions were characterized by a more severe acute PFA response with contraction band necrosis, myocytolysis and nuclear pyknosis in adjacent myocardium, in addition to microhemorrhages.
Infusing calcium chloride locally after PFA markedly improves the immediate efficacy of electroporation in porcine atria. This study suggests that calcium electroporation could bolster PFA outcomes without higher energy levels, potentially diminishing associated risks. These preliminary findings warrant further research into the long-term efficacy and potential clinical application of calcium electroporation in PFA.
脉冲场消融(PFA)已成为一种治疗心律失常的创新疗法。与PFA在实体肿瘤中的应用类似,氯化钙(CaCl)作为一种辅助疗法,即钙电穿孔,可能会增强PFA的凋亡作用。我们提出,心房中的PFA可通过PFA形成的孔增强钙摄取,从而通过利用PFA的通透化作用,即使在较低功率水平下也能提高消融效果。
我们对7头猪的心房进行了体内消融,使用低PFA功率(250 V,20 μs,50个脉冲,间隔200 ms)。PFA后,我们通过导管尖端将200 mg/2 ml CaCl(钙组)或生理盐水(对照组)随机注入消融部位。我们评估了PFA后心电图电压幅度的降低、心电图(ECG)参数、消融灶参数和组织学情况。
检查了对照组和钙组的19个病灶。对照组病灶在PFA后电压无下降,而钙处理组病灶电压显著降低。大体病理学显示,病灶组之间在最大病灶表面直径、深度和体积方面存在明显差异。组织学上,钙组病灶的特征是急性PFA反应更严重,伴有收缩带坏死、肌细胞溶解和相邻心肌细胞核固缩,此外还有微出血。
PFA后局部注入氯化钙可显著提高猪心房电穿孔的即时效果。这项研究表明,钙电穿孔可在不提高能量水平的情况下改善PFA的效果,可能会降低相关风险。这些初步发现值得进一步研究钙电穿孔在PFA中的长期疗效和潜在临床应用。